JOEL BIRNBAUM, PhD
Joel S. Birnbaum, Ph.D., until June of 2005
was Technical Advisor to the chairman and
CEO of the Hewlett-Packard Company, responsible
for helping the company to set its technology
directions and to communicate this strategy
to the marketplace.
Before assuming this role, Dr. Birnbaum was
Senior Vice President for research and development
(R&D), responsible for the coordination
of worldwide activities in R&D, and Director
of HP Laboratories; he retired from both positions
in 1999. As HP's a member of the management
staff, Joel Birnbaum coordinated Hewlett-Packard's
global research and development, directed
central research, and acted as the technology
spokesman for the company. Among the many
technologies developed under his direction
were the architectural precursor for all Hewlett-Packard's
RISC computers, and the ink jet printing technology.
From 1986 to 1991, he was VP and general manager
of the Information Technology group, responsible
for the development of all core hardware platforms
and all systems software for the world wide
product line.
Dr. Birnbaum joined Hewlett-Packard in 1980
after 15 years at IBM Corporation's Thomas
J. Watson Research Center in Yorktown Heights,
N.Y., where he last served as director of
computer sciences.
Dr. Birnbaum has been elected to the National
Academy of Engineering and the Royal Academy
of Engineering of the UK. He is a Fellow of
the Institute of Electrical and Electronic
Engineers, the Association of Computing Machinery.,
the California Council on Science and Technology,
the American Academy of Arts and Sciences,
and is a Sheffield Fellow of Yale University.
He has been granted an honorary doctorate
by the Technion University of Israel and was
the year 2000 winner of the IEEE Weber Prize,
given for career engineering management achievement.
Joel Birnbaum's board memberships include
the Corporation for National Research Initiatives,
Qlogic Corporation, the Technion University
of Israel, the Search for Extraterrestial
Life Institute (SETI), and the Monterey Bay
Aquarium Research Institute. Joel Birnbaum
holds a Ph.D. and M.S. in nuclear physics,
both from Yale University. He obtained a B.S.
degree in Engineering Physics from Cornell
University.
WILLIAM G. BRADLEY, MD, PhD, FACR
Dr. Bradley is Professor and Chairman, Department of Radiology, at UCSD. He received his BS at Caltech and his PhD at Princeton, both in Chemical Engineering. He received his MD and did his Radiology residency at UCSF. He has published over 170 papers, 52 chapters, and 19 textbooks, including Magnetic Resonance Imaging (3rd Edition), coedited with David Stark. He was honored with the Gold Medal of the ISMRM in 1989 and that of the RSNA in 2003. He served on the Board of the Research and Education Foundation of the RSNA 1995-2001 and currently chairs the Fund Development Committee of that society. He was on the Board of Chancellors of the American College of Radiology where he chaired the Commission on Neuroradiology and MRI from 1999 to 2005 and served as Vice President 2005-2006.
WILLIAM CLARKE, MD
Bill Clarke was appointed Executive Vice
President and Chief Technology & Medical
Officer of GE Healthcare in April 2004. In
this role, Bill oversees technology development
for GE Healthcare globally.
Previously, Bill oversaw the Global Research,
Development, Medical, and Regulatory functions
as Executive Vice President of R&D, Amersham
Health. He also is actively involved in a
number of United States health policy issues.
Before joining Amersham in December 2000,
Bill spent three years as Director of Biological
Sciences at Glaxo Wellcome U.K. with responsibility
for pre-clinical disease-focused biological
research. He also was Chair of the Glaxo Wellcome
Global Imaging Strategy Committee, formulating
corporate strategy and developing significant
business and governmental partnerships.
Before joining the pharmaceutical industry,
Bill held a number of academic positions,
most recently as Associate Professor at the
Department of Anesthesiology/Critical Care
Medicine and Pediatrics at the University
of Washington School of Medicine.
Bill received his AB in Chemistry, MSc in
Physiology and Pharmacology, and MD from Duke
University. He was also educated at the University
of Washington School of Medicine, the University
of Pennsylvania, and the Stockholm School
of Economics.
FERENC A. JOLESZ, MD
Ferenc Jolesz has achieved international recognition
as one of the great innovators and leaders
in radiological research. Indeed, he continues
to distinguish himself with ongoing cutting
edge research in magnetic resonance imaging
and image-guided therapy.
In 1998, Dr. Jolesz was appointed B.Leonard
Holman Professor of Radiology at Harvard Medical
School and Vice Chairman for Research at the
Department of Radiology of Brigham and Women's
Hospital in 2000; he has been Director of
the Division of Magnetic Resonance Imaging
since 1988. In 1993, Dr. Jolesz established
the Image-Guided Therapy Program at the Brigham
and Women's Hospital, which includes an internationally
recognized intraoperative MRI facility, the
Surgical Planning Laboratory, and the Therapeutic
Ultrasound Laboratory-the center of ground
breaking therapeutic technology development.
In 2002, Dr. Jolesz was appointed Director
of the Neuroimaging Core of the Harvard Center
for Neurodegeneration and Repair. Dr. Jolesz
maintains a research focus in basic and clinical
neurosciences, magnetic resonance imaging,
and image guided therapy. Along with a highly
trained and dedicated research staff of over
100, Dr. Jolesz spearheads the development
and implementation of innovative image processing
methods and has brought several minimally
invasive therapies into successful clinical
application. Dr. Jolesz is also credited with
developing, refining, and introducing into
clinical practice the idea of direct, real
time MR image-guided surgical interventions.
In collaboration with key industrial partners,
Dr. Jolesz has driven the development of various
image-guided therapy delivery systems in current
use in several sites around the world. Among
these, interventional an interoperative MRI,
MRI -guided laser, cryoablation, and MRI-guided
brachytherapy are the most significant. Dr.
Jolesz is further recognized for perfecting
the use of high in intensity-focused ultrasound
as a tissue ablation tool and integrating
it with MR imaging guidance systems. Dr. Jolesz'
pioneering research in image-guided brain
surgery in particular has had an enormous
impact on the fields of modern Radiology and
Neurosurgery. Indeed, his contributions are
widely acknowledged in the literature and
in medical curricula throughout the w orld.
Dr. Jolesz' substantial research support comes
from a variety of public and private sources,
including several NIH grants of which he is
principle Investigator, corporate-sponsored
clinical trials, and industry supported research
efforts. He belongs to several professional
societies and serves on the editorial boards
of prestigious peer review journals. Commensurate
with his prolific research, Dr. Jolesz has
published over 300 articles in scholarly,
peer reviewed journals and has contributed
many chapters and review articles in the fields
of surgery, computer science, neurology, and
radiology.
KING LI, MD
Dr. Li is the Chair of Radiology at the Methodist
Hospital in Houston, Texas. Prior to joining
the Methodist Hospital he was the Associate
Director of the National Institute of Health
Clinical Center and the Chief of Radiology
for the Imaging Sciences Program. Dr. Li was
on faculty in Stanford University for ten
years prior to joining the NIH. He has eight
issued and three pending patents. A prolific
researcher, Dr, Li has published over one
hundred scientific articles and contributed
to numbers books. Well acknowledged by his
peers, Dr. Li has won several research awards
as well as received numerous grants from government,
industry and private sources.
LADISLAU STEINER, MD, PhD
Dr. Steiner is the Director of the Lars Leskell
Gamma Knife Center for Surgery and Alumni
Professor of Neurological Surgery and Professor
of Radiology at the University of Virginia.
Prior to UVa, he worked from 1962 to 1987
at the Neurosurgical Department of the Karolinksa
Hospital where his last position was Chief
Dr. Steiner has published extensively on,
among other subjects, subarachnoid hemorrhage,
aneurysms, AVMs, pituitary adenomas, meningiomas,
vestibular schwannomas, metastatic brain tumors,
low and high grade astrocytomas, methods of
volume assessment on CT and MRI, immunology
in gliomas, prostaglandins, leucotrens and
Gamma surgery. He devised the first hemostatic
titanium clip and, among other neurosurgical
instruments, a stereotactic guide for microsurgery.
Dr. Steiner is a founding, corresponding or
honorific member or president of multiple
national and international neurosurgical societies.
He was the Sheline and Leskell lecturer. He
received the Sugita award in 2001 from the
International Society of Neurological Technology
and Instrument Invention and the World Federation
of Neurosurgical Societies Gold Medal of Honor,
2003 and the Markusovszy award, 2000. He is
a scientific reviewer for the Journal of Neurosurgery,
The Neurosurgery, the Acta Neurochirugica,
the Harvard Press and Surgical Neurology.
Dr. Steiner graduated from the medical school
at University of Cluj-Napoca and received
his PhD from the Karolinksa Institute. |
|
